Mississippi requires three tests every year. The state should explain why.
Rule 1.7(L) hard codes three in-office drug tests per calendar year for covered Schedule II chronic pain treatment. Ask the Board to replace the calendar command with individualized, documented clinical judgment.
The mandate is fixed. The remedy is narrow.
Three every year
For the covered treatment category, Rule 1.7(L) requires at least three in-office drug tests in every calendar year.
Not a suggestion
Rule 1.15 connects violations of the controlled substance rules to professional discipline. The testing calendar carries regulatory force.
One sentence
Replace the fixed minimum with a documented decision based on the individual patient, while keeping testing fully available.
Change one sentence. Keep testing available. Return frequency to documented clinical judgment.
Separate binding authority from clinical guidance.
Binding Mississippi law
Board rules define the physician obligation and the disciplinary exposure. This is the controlling layer.
Clinical evidence
National guidance can test whether a fixed schedule remains justified. It does not itself rewrite Mississippi law.
Public record
Adoption files, retention reviews, complaints, enforcement records, costs, and access data reveal what evidence actually sustains the mandate.
Parallel systems
Nursing, workers compensation, Medicaid, and private practice policies require separate analysis. They should not be collapsed into the physician rule.
Ask the body that can change the rule.
Mississippi State Board of Medical Licensure. It owns the physician licensing rule and the first decision.
Request referral to the Board committee responsible for rules, regulation, and legislation, followed by action on the public Board record.
Mississippi physicians and the Mississippi State Medical Association can evaluate the clinical case. They are potential validators, not presumed allies.
Secretary of State administrative processes and occupational licensing review remain later levers if the ordinary Board route fails.
The calendar is written into licensure.
Rule 1.7(L) states that when Schedule II medication is written for chronic non-cancer or non-terminal pain, in-office drug testing must be performed at least three times every calendar year. The required panel includes opioids, benzodiazepines, amphetamines, cocaine, and cannabis.
Rule 1.15 supplies the consequence. A violation of the preceding controlled substance rules may be treated as prescribing outside legitimate professional practice and can support discipline.
This is not a fight over whether testing may ever be useful. It is a demand for evidence before the state commands the same annual minimum for every covered patient.
Amend the first sentence of Rule 1.7(L).
Remove
The fixed requirement for at least three tests in every calendar year.
Replace
A documented decision that sets testing and frequency according to the individual patient’s clinical circumstances.
Preserve
Testing authority, documentation duties, prescription monitoring review, and discipline for genuinely unsafe or illegitimate prescribing.
Clarify
Clinically warranted testing may be more frequent. The reform removes a floor, not the physician’s ability to respond to evidence.
A narrow amendment the Board can evaluate.
Proposed replacement
When Schedule II medication is written for the treatment of chronic non-cancer or non-terminal pain, the licensee shall document, before initiation and periodically thereafter at least annually, consideration of the benefits and risks of in-office drug testing. Whether testing is ordered, and its frequency, shall be determined according to the individual patient’s clinical circumstances.
This language preserves review and documentation. It changes only the categorical calendar minimum. Final rule text should be reviewed against the Board’s current codified language before filing.
Build a record before building pressure.
Archive the rule. Preserve the current text of Rules 1.7 and 1.15 with the date accessed.
Submit the narrow request. Ask the Board to refer the first sentence of Rule 1.7(L) for committee review and amendment.
Request the evidence. Seek adoption and retention records, cited evidence, disciplinary use, patient cost and access analysis, and any review of the 2022 CDC guideline.
Obtain clinical review. Ask Mississippi physicians and organized medicine to assess whether a universal three-test floor remains clinically defensible.
Create a public decision. Put the request, the record, and the Board response into a traceable public process.
Conform other systems later. If the physician rule moves, address nursing and workers compensation through their own authorities.
Measure movement, not attention.
One reform does not automatically repair every rule.
Advanced practice nursing
A separate nursing rule carries its own testing frequency. Treat it as a conforming track after the physician rule moves.
Workers compensation
Mississippi workers compensation materials use a separate annual testing minimum. Its authority and record must be addressed independently.
Medical cannabis
The panel expressly includes cannabis while Mississippi permits lawful medical use. Request existing records defining how lawful results are interpreted before proposing new language.
Dosage rules
The state’s MME architecture is a separate second phase. Do not dilute the first campaign by leading with it.
Escalate only as far as the record requires.
Use the Board’s ordinary rule review channel and give it a defined, answerable amendment.
Use the public records process. Board rules provide an early response framework measured in business days.
Add credible Mississippi clinical support and public comment if the rule enters formal review.
Use broader occupational licensing oversight only if the Board declines a good-faith evidence review or leaves the request unanswered.
The off ramp is real: stop escalating when transparent, good-faith rulemaking begins.
Read the rule. Request the record. Keep the claim precise.
Do not claim more than the evidence can carry.
Confirmed
The physician rule contains a fixed three-test annual minimum for the covered treatment category.
Not yet confirmed
The Board’s current empirical basis, patient cost analysis, enforcement pattern, and interpretation of lawful cannabis results.
Method
Use public records to close those gaps. Update the campaign when the record changes. Do not turn an unanswered question into a factual accusation.
The mandate is a sentence. The remedy can begin with one.
Ask for the evidence. Put the answer on the record. Replace a fixed calendar with accountable clinical judgment.